Date: Thursday, October 30th, 2025 Time: 2:00pm - 3:00pm ET       WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia. OBJECTIVE: To provide an update on prescribing information of the recently FDA-approved indication in patients with hemophilia A or B without inhibitors, and supporting data from the explorer8 trial. AUDIENCE: Read the full article...

Date: Thursday, November 6th, 2025 Time: 1:00pm - 2:00pm ET           WEBINAR TOPIC: Jivi — With Them as They Grow™ Clinical Study Data for Children 7 to 11 Years. OBJECTIVE: This session provides a clinical review of safety and efficacy data drawn from both the PROTECT Kids and Alfa-PROTECT studies. Data Read the full article...

Date: Wednesday, November 12th, 2025 Time: 1:00pm - 2:00pm ET       WEBINAR TOPIC: VONVENDI® Approved for Adults and Pediatric Patients. OBJECTIVE: Understand the underlying mechanism of VWD and the role of VWF. Review unmet needs in the treatment of VWD. Identify the unique characteristics of VONVENDI as the first and only recombinant treatment Read the full article...

Date: Thursday, November 13th, 2025 Time: 1:00pm - 2:00pm ET         WEBINAR TOPIC: The HEMGENIX Toolkit OBJECTIVE: Overview of the tools and resources available to treatment centers to help support patients eligible and interested in HEMGENIX AUDIENCE: All HTC Staff. SPEAKER: Bonnie Ben-Shmuel Bonnie Ben-Shmuel is a seasoned biopharmaceutical marketing leader with Read the full article...